227 related articles for article (PubMed ID: 30530232)
1. Current treatment strategies in refractory chronic pruritus.
Pereira MP; Mittal A; Ständer S
Curr Opin Pharmacol; 2019 Jun; 46():1-6. PubMed ID: 30530232
[TBL] [Abstract][Full Text] [Related]
2. Chronic Pruritus: Current and Emerging Treatment Options.
Pereira MP; Ständer S
Drugs; 2017 Jun; 77(9):999-1007. PubMed ID: 28466423
[TBL] [Abstract][Full Text] [Related]
3. [Modern systemic therapy for pruritus].
Metz M; Pereira MP
Hautarzt; 2020 Jul; 71(7):518-524. PubMed ID: 32399670
[TBL] [Abstract][Full Text] [Related]
4. [Therapy for chronic pruritus-light at the end of a long tunnel?].
Pereira MP; Salzmann S; Ständer S; Staubach P; Metz M
Internist (Berl); 2020 Oct; 61(10):1076-1086. PubMed ID: 32676722
[TBL] [Abstract][Full Text] [Related]
5. Novel drugs for the treatment of chronic pruritus.
Pereira MP; Ständer S
Expert Opin Investig Drugs; 2018 Dec; 27(12):981-988. PubMed ID: 30426802
[TBL] [Abstract][Full Text] [Related]
6. Therapy for pruritus in the elderly: a review of treatment developments.
Pereira MP; Ständer S
Expert Opin Pharmacother; 2018 Apr; 19(5):443-450. PubMed ID: 29493371
[TBL] [Abstract][Full Text] [Related]
7. Chronic pruritus: targets, mechanisms and future therapies.
Pogatzki-Zahn E; Marziniak M; Schneider G; Luger TA; Ständer S
Drug News Perspect; 2008 Dec; 21(10):541-51. PubMed ID: 19221635
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of pruritus.
Ständer S; Weisshaar E
Expert Opin Emerg Drugs; 2012 Sep; 17(3):335-45. PubMed ID: 22870909
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants as antipruritic agents: A review.
Kaur R; Sinha VR
Eur Neuropsychopharmacol; 2018 Mar; 28(3):341-352. PubMed ID: 29456150
[TBL] [Abstract][Full Text] [Related]
10. Drugs on the Horizon for Chronic Pruritus.
McEwen MW; Fite EM; Yosipovitch G; Patel T
Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
[TBL] [Abstract][Full Text] [Related]
11. Emerging Therapeutic Options for Chronic Pruritus.
Reszke R; Krajewski P; Szepietowski JC
Am J Clin Dermatol; 2020 Oct; 21(5):601-618. PubMed ID: 32607945
[TBL] [Abstract][Full Text] [Related]
12. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
13. Treating pruritus. What's new in safe relief of symptoms?
Millikan LE
Postgrad Med; 1996 Jan; 99(1):173-6, 179-84. PubMed ID: 8539203
[TBL] [Abstract][Full Text] [Related]
14. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
15. Pruritus in connective tissue and other common systemic disease states.
Galatian A; Stearns G; Grau R
Cutis; 2009 Oct; 84(4):207-14. PubMed ID: 19911676
[TBL] [Abstract][Full Text] [Related]
16. Itch Management: Topical Agents.
Metz M; Staubach P
Curr Probl Dermatol; 2016; 50():40-5. PubMed ID: 27578070
[TBL] [Abstract][Full Text] [Related]
17. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
18. Review article: pruritus in cholestatic and other liver diseases.
Mela M; Mancuso A; Burroughs AK
Aliment Pharmacol Ther; 2003 Apr; 17(7):857-70. PubMed ID: 12656688
[TBL] [Abstract][Full Text] [Related]
19. Current and emerging systemic treatments targeting the neural system for chronic pruritus.
Golpanian RS; Yosipovitch G
Expert Opin Pharmacother; 2020 Sep; 21(13):1629-1636. PubMed ID: 32515664
[TBL] [Abstract][Full Text] [Related]
20. Itch Management in the Elderly.
Leslie TA
Curr Probl Dermatol; 2016; 50():192-201. PubMed ID: 27578088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]